Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2425561
Max Phase: Preclinical
Molecular Formula: C23H24ClF3N2O3
Molecular Weight: 468.90
Molecule Type: Small molecule
Associated Items:
ID: ALA2425561
Max Phase: Preclinical
Molecular Formula: C23H24ClF3N2O3
Molecular Weight: 468.90
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(N[C@@H](CC1CCCCC1)C(=O)Nc1cccc(C(F)(F)F)c1)c1cc(Cl)ccc1O
Standard InChI: InChI=1S/C23H24ClF3N2O3/c24-16-9-10-20(30)18(13-16)21(31)29-19(11-14-5-2-1-3-6-14)22(32)28-17-8-4-7-15(12-17)23(25,26)27/h4,7-10,12-14,19,30H,1-3,5-6,11H2,(H,28,32)(H,29,31)/t19-/m0/s1
Standard InChI Key: GEDNWCDPRLAKEC-IBGZPJMESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 468.90 | Molecular Weight (Monoisotopic): 468.1428 | AlogP: 5.77 | #Rotatable Bonds: 6 |
Polar Surface Area: 78.43 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 7.66 | CX Basic pKa: | CX LogP: 6.48 | CX LogD: 6.29 |
Aromatic Rings: 2 | Heavy Atoms: 32 | QED Weighted: 0.50 | Np Likeness Score: -1.08 |
1. Imramovský A, Jorda R, Pauk K, Rezníčková E, Dušek J, Hanusek J, Kryštof V.. (2013) Substituted 2-hydroxy-N-(arylalkyl)benzamides induce apoptosis in cancer cell lines., 68 [PMID:23981532] [10.1016/j.ejmech.2013.08.009] |
Source(1):